Role of (18F) 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 46

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

491

HTML

4757

Figures (1-4)

265

Tables (1-4)

216

Sum=5729

Dec 14, 2011 (publication date) through Nov 18, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Dec 14, 2011; 17(46): 5059-5074
Published online Dec 14, 2011. doi: 10.3748/wjg.v17.i46.5059

Full Size Figure Download Figure

Figure 3 (¹⁸F) 2-fluoro-2-deoxyglucose-positron emission tomography response in a patient with a proximal gastric cancer receiving chemotherapy.

Citation: Smyth EC, Shah MA. Role of (¹⁸F) 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies. World J Gastroenterol 2011; 17(46): 5059-5074
URL: https://www.wjgnet.com/1007-9327/full/v17/i46/5059.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i46.5059